Juice, Nectar and Still Drinks
Juice, Nectar and Still Drinks market is segmented by region (country), players, by Type and by A ... Read More
1 Study Coverage 1.1 Bio Similars/Subsequent Entry Biologic Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Introduction 1.2 Global Bio Similars/Subsequent Entry Biologic Outlook 2017 VS 2022 VS 2028 1.2.1 Global Bio Similars/Subsequent Entry Biologic Market Size for the Year 2017-2028 1.2.2 Global Bio Similars/Subsequent Entry Biologic Market Size for the Year 2017-2028 1.3 Bio Similars/Subsequent Entry Biologic Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Bio Similars/Subsequent Entry Biologic in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Bio Similars/Subsequent Entry Biologic Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Bio Similars/Subsequent Entry Biologic Market Dynamics 1.4.1 Bio Similars/Subsequent Entry Biologic Industry Trends 1.4.2 Bio Similars/Subsequent Entry Biologic Market Drivers 1.4.3 Bio Similars/Subsequent Entry Biologic Market Challenges 1.4.4 Bio Similars/Subsequent Entry Biologic Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Bio Similars/Subsequent Entry Biologic by Type 2.1 Bio Similars/Subsequent Entry Biologic Market Segment by Type 2.1.1 Monoclonal Antibodies 2.1.2 Interferon 2.1.3 Erythropoietin 2.1.4 Insulin 2.1.5 Vaccines 2.1.6 Other 2.2 Global Bio Similars/Subsequent Entry Biologic Market Size by Type (2017, 2022 & 2028) 2.3 Global Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2028) 2.4 United States Bio Similars/Subsequent Entry Biologic Market Size by Type (2017, 2022 & 2028) 2.5 United States Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2028) 3 Bio Similars/Subsequent Entry Biologic by Application 3.1 Bio Similars/Subsequent Entry Biologic Market Segment by Application 3.1.1 Tumor 3.1.2 Diabetes 3.1.3 Cardiovascular 3.1.4 Hemophilia 3.1.5 Other 3.2 Global Bio Similars/Subsequent Entry Biologic Market Size by Application (2017, 2022 & 2028) 3.3 Global Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2028) 3.4 United States Bio Similars/Subsequent Entry Biologic Market Size by Application (2017, 2022 & 2028) 3.5 United States Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2028) 4 Global Bio Similars/Subsequent Entry Biologic Competitor Landscape by Company 4.1 Global Bio Similars/Subsequent Entry Biologic Market Size by Company 4.1.1 Top Global Bio Similars/Subsequent Entry Biologic Companies Ranked by Revenue (2021) 4.1.2 Global Bio Similars/Subsequent Entry Biologic Revenue by Player (2017-2022) 4.2 Global Bio Similars/Subsequent Entry Biologic Concentration Ratio (CR) 4.2.1 Bio Similars/Subsequent Entry Biologic Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Bio Similars/Subsequent Entry Biologic in 2021 4.2.3 Global Bio Similars/Subsequent Entry Biologic Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Bio Similars/Subsequent Entry Biologic Headquarters, Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Type 4.3.1 Global Bio Similars/Subsequent Entry Biologic Headquarters and Area Served 4.3.2 Global Bio Similars/Subsequent Entry Biologic Companies Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Bio Similars/Subsequent Entry Biologic Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Bio Similars/Subsequent Entry Biologic Market Size by Company 4.5.1 Top Bio Similars/Subsequent Entry Biologic Players in United States, Ranked by Revenue (2021) 4.5.2 United States Bio Similars/Subsequent Entry Biologic Revenue by Players (2020, 2021 & 2022) 5 Global Bio Similars/Subsequent Entry Biologic Market Size by Region 5.1 Global Bio Similars/Subsequent Entry Biologic Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Bio Similars/Subsequent Entry Biologic Market Size by Region (2017-2028) 5.2.1 Global Bio Similars/Subsequent Entry Biologic Market Size by Region: 2017-2022 5.2.2 Global Bio Similars/Subsequent Entry Biologic Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Bio Similars/Subsequent Entry Biologic Market Size YoY Growth 2017-2028 6.1.2 North America Bio Similars/Subsequent Entry Biologic Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Bio Similars/Subsequent Entry Biologic Market Size YoY Growth 2017-2028 6.3.2 Europe Bio Similars/Subsequent Entry Biologic Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Bio Similars/Subsequent Entry Biologic Market Size YoY Growth 2017-2028 6.4.2 Latin America Bio Similars/Subsequent Entry Biologic Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Bio Similars/Subsequent Entry Biologic Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Bio Similars/Subsequent Entry Biologic Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Sun Pharma 7.1.1 Sun Pharma Company Details 7.1.2 Sun Pharma Business Overview 7.1.3 Sun Pharma Bio Similars/Subsequent Entry Biologic Introduction 7.1.4 Sun Pharma Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.1.5 Sun Pharma Recent Development 7.2 Synthon Pharmaceuticals 7.2.1 Synthon Pharmaceuticals Company Details 7.2.2 Synthon Pharmaceuticals Business Overview 7.2.3 Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Introduction 7.2.4 Synthon Pharmaceuticals Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.2.5 Synthon Pharmaceuticals Recent Development 7.3 Teva Pharmaceutical Industries 7.3.1 Teva Pharmaceutical Industries Company Details 7.3.2 Teva Pharmaceutical Industries Business Overview 7.3.3 Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Introduction 7.3.4 Teva Pharmaceutical Industries Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.3.5 Teva Pharmaceutical Industries Recent Development 7.4 LG Life Sciences 7.4.1 LG Life Sciences Company Details 7.4.2 LG Life Sciences Business Overview 7.4.3 LG Life Sciences Bio Similars/Subsequent Entry Biologic Introduction 7.4.4 LG Life Sciences Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.4.5 LG Life Sciences Recent Development 7.5 Celltrion Biocon 7.5.1 Celltrion Biocon Company Details 7.5.2 Celltrion Biocon Business Overview 7.5.3 Celltrion Biocon Bio Similars/Subsequent Entry Biologic Introduction 7.5.4 Celltrion Biocon Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.5.5 Celltrion Biocon Recent Development 7.6 Hospira 7.6.1 Hospira Company Details 7.6.2 Hospira Business Overview 7.6.3 Hospira Bio Similars/Subsequent Entry Biologic Introduction 7.6.4 Hospira Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.6.5 Hospira Recent Development 7.7 Merck 7.7.1 Merck Company Details 7.7.2 Merck Business Overview 7.7.3 Merck Bio Similars/Subsequent Entry Biologic Introduction 7.7.4 Merck Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.7.5 Merck Recent Development 7.8 Biogen idec 7.8.1 Biogen idec Company Details 7.8.2 Biogen idec Business Overview 7.8.3 Biogen idec Bio Similars/Subsequent Entry Biologic Introduction 7.8.4 Biogen idec Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.8.5 Biogen idec Recent Development 7.9 Genentech (Roche) 7.9.1 Genentech (Roche) Company Details 7.9.2 Genentech (Roche) Business Overview 7.9.3 Genentech (Roche) Bio Similars/Subsequent Entry Biologic Introduction 7.9.4 Genentech (Roche) Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.9.5 Genentech (Roche) Recent Development 7.10 Pfizer 7.10.1 Pfizer Company Details 7.10.2 Pfizer Business Overview 7.10.3 Pfizer Bio Similars/Subsequent Entry Biologic Introduction 7.10.4 Pfizer Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.10.5 Pfizer Recent Development 7.11 Celltrion 7.11.1 Celltrion Company Details 7.11.2 Celltrion Business Overview 7.11.3 Celltrion Bio Similars/Subsequent Entry Biologic Introduction 7.11.4 Celltrion Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.11.5 Celltrion Recent Development 7.12 Biocon 7.12.1 Biocon Company Details 7.12.2 Biocon Business Overview 7.12.3 Biocon Bio Similars/Subsequent Entry Biologic Introduction 7.12.4 Biocon Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.12.5 Biocon Recent Development 7.13 Amgen 7.13.1 Amgen Company Details 7.13.2 Amgen Business Overview 7.13.3 Amgen Bio Similars/Subsequent Entry Biologic Introduction 7.13.4 Amgen Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.13.5 Amgen Recent Development 7.14 Samsung Biologics 7.14.1 Samsung Biologics Company Details 7.14.2 Samsung Biologics Business Overview 7.14.3 Samsung Biologics Bio Similars/Subsequent Entry Biologic Introduction 7.14.4 Samsung Biologics Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.14.5 Samsung Biologics Recent Development 7.15 Mylan 7.15.1 Mylan Company Details 7.15.2 Mylan Business Overview 7.15.3 Mylan Bio Similars/Subsequent Entry Biologic Introduction 7.15.4 Mylan Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.15.5 Mylan Recent Development 7.16 Dr. Reddy's Laboratories 7.16.1 Dr. Reddy's Laboratories Company Details 7.16.2 Dr. Reddy's Laboratories Business Overview 7.16.3 Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Introduction 7.16.4 Dr. Reddy's Laboratories Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.16.5 Dr. Reddy's Laboratories Recent Development 7.17 Stada Arzneimittel AG 7.17.1 Stada Arzneimittel AG Company Details 7.17.2 Stada Arzneimittel AG Business Overview 7.17.3 Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Introduction 7.17.4 Stada Arzneimittel AG Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.17.5 Stada Arzneimittel AG Recent Development 7.18 AbbVie 7.18.1 AbbVie Company Details 7.18.2 AbbVie Business Overview 7.18.3 AbbVie Bio Similars/Subsequent Entry Biologic Introduction 7.18.4 AbbVie Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.18.5 AbbVie Recent Development 7.19 Sanofi-Aventis 7.19.1 Sanofi-Aventis Company Details 7.19.2 Sanofi-Aventis Business Overview 7.19.3 Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Introduction 7.19.4 Sanofi-Aventis Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.19.5 Sanofi-Aventis Recent Development 7.20 Johnson & Johnson 7.20.1 Johnson & Johnson Company Details 7.20.2 Johnson & Johnson Business Overview 7.20.3 Johnson & Johnson Bio Similars/Subsequent Entry Biologic Introduction 7.20.4 Johnson & Johnson Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.20.5 Johnson & Johnson Recent Development 7.21 Novo Nordisk 7.21.1 Novo Nordisk Company Details 7.21.2 Novo Nordisk Business Overview 7.21.3 Novo Nordisk Bio Similars/Subsequent Entry Biologic Introduction 7.21.4 Novo Nordisk Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.21.5 Novo Nordisk Recent Development 7.22 Eli Lilly 7.22.1 Eli Lilly Company Details 7.22.2 Eli Lilly Business Overview 7.22.3 Eli Lilly Bio Similars/Subsequent Entry Biologic Introduction 7.22.4 Eli Lilly Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.22.5 Eli Lilly Recent Development 7.23 Novartis 7.23.1 Novartis Company Details 7.23.2 Novartis Business Overview 7.23.3 Novartis Bio Similars/Subsequent Entry Biologic Introduction 7.23.4 Novartis Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.23.5 Novartis Recent Development 7.24 3sbio 7.24.1 3sbio Company Details 7.24.2 3sbio Business Overview 7.24.3 3sbio Bio Similars/Subsequent Entry Biologic Introduction 7.24.4 3sbio Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.24.5 3sbio Recent Development 7.25 Biotech 7.25.1 Biotech Company Details 7.25.2 Biotech Business Overview 7.25.3 Biotech Bio Similars/Subsequent Entry Biologic Introduction 7.25.4 Biotech Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.25.5 Biotech Recent Development 7.26 Gelgen 7.26.1 Gelgen Company Details 7.26.2 Gelgen Business Overview 7.26.3 Gelgen Bio Similars/Subsequent Entry Biologic Introduction 7.26.4 Gelgen Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.26.5 Gelgen Recent Development 7.27 Innovent 7.27.1 Innovent Company Details 7.27.2 Innovent Business Overview 7.27.3 Innovent Bio Similars/Subsequent Entry Biologic Introduction 7.27.4 Innovent Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.27.5 Innovent Recent Development 7.28 Dong Bao 7.28.1 Dong Bao Company Details 7.28.2 Dong Bao Business Overview 7.28.3 Dong Bao Bio Similars/Subsequent Entry Biologic Introduction 7.28.4 Dong Bao Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.28.5 Dong Bao Recent Development 7.29 Ganlee 7.29.1 Ganlee Company Details 7.29.2 Ganlee Business Overview 7.29.3 Ganlee Bio Similars/Subsequent Entry Biologic Introduction 7.29.4 Ganlee Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) 7.29.5 Ganlee Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer
List of Tables Table 1. Bio Similars/Subsequent Entry Biologic Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Bio Similars/Subsequent Entry Biologic Market Trends Table 3. Bio Similars/Subsequent Entry Biologic Market Drivers Table 4. Bio Similars/Subsequent Entry Biologic Market Challenges Table 5. Bio Similars/Subsequent Entry Biologic Market Restraints Table 6. Global Bio Similars/Subsequent Entry Biologic Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Bio Similars/Subsequent Entry Biologic Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Bio Similars/Subsequent Entry Biologic Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Bio Similars/Subsequent Entry Biologic Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Bio Similars/Subsequent Entry Biologic Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Bio Similars/Subsequent Entry Biologic Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Bio Similars/Subsequent Entry Biologic Revenue Share by Player, 2017-2022 Table 13. Global Bio Similars/Subsequent Entry Biologic Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Bio Similars/Subsequent Entry Biologic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio Similars/Subsequent Entry Biologic as of 2021) Table 15. Top Players of Bio Similars/Subsequent Entry Biologic in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Bio Similars/Subsequent Entry Biologic Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Bio Similars/Subsequent Entry Biologic Players in United States Market, Ranking by Revenue (2021) Table 20. United States Bio Similars/Subsequent Entry Biologic Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Bio Similars/Subsequent Entry Biologic Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Bio Similars/Subsequent Entry Biologic Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Bio Similars/Subsequent Entry Biologic Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Bio Similars/Subsequent Entry Biologic Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Bio Similars/Subsequent Entry Biologic Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Bio Similars/Subsequent Entry Biologic Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Bio Similars/Subsequent Entry Biologic Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Bio Similars/Subsequent Entry Biologic Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Bio Similars/Subsequent Entry Biologic Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Sun Pharma Company Details Table 31. Sun Pharma Business Overview Table 32. Sun Pharma Bio Similars/Subsequent Entry Biologic Product Table 33. Sun Pharma Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 34. Sun Pharma Recent Development Table 35. Synthon Pharmaceuticals Company Details Table 36. Synthon Pharmaceuticals Business Overview Table 37. Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Product Table 38. Synthon Pharmaceuticals Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 39. Synthon Pharmaceuticals Recent Development Table 40. Teva Pharmaceutical Industries Company Details Table 41. Teva Pharmaceutical Industries Business Overview Table 42. Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Product Table 43. Teva Pharmaceutical Industries Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 44. Teva Pharmaceutical Industries Recent Development Table 45. LG Life Sciences Company Details Table 46. LG Life Sciences Business Overview Table 47. LG Life Sciences Bio Similars/Subsequent Entry Biologic Product Table 48. LG Life Sciences Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 49. LG Life Sciences Recent Development Table 50. Celltrion Biocon Company Details Table 51. Celltrion Biocon Business Overview Table 52. Celltrion Biocon Bio Similars/Subsequent Entry Biologic Product Table 53. Celltrion Biocon Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 54. Celltrion Biocon Recent Development Table 55. Hospira Company Details Table 56. Hospira Business Overview Table 57. Hospira Bio Similars/Subsequent Entry Biologic Product Table 58. Hospira Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 59. Hospira Recent Development Table 60. Merck Company Details Table 61. Merck Business Overview Table 62. Merck Bio Similars/Subsequent Entry Biologic Product Table 63. Merck Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 64. Merck Recent Development Table 65. Biogen idec Company Details Table 66. Biogen idec Business Overview Table 67. Biogen idec Bio Similars/Subsequent Entry Biologic Product Table 68. Biogen idec Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 69. Biogen idec Recent Development Table 70. Genentech (Roche) Company Details Table 71. Genentech (Roche) Business Overview Table 72. Genentech (Roche) Bio Similars/Subsequent Entry Biologic Product Table 73. Genentech (Roche) Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 74. Genentech (Roche) Recent Development Table 75. Pfizer Company Details Table 76. Pfizer Business Overview Table 77. Pfizer Bio Similars/Subsequent Entry Biologic Product Table 78. Pfizer Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 79. Pfizer Recent Development Table 80. Celltrion Company Details Table 81. Celltrion Business Overview Table 82. Celltrion Bio Similars/Subsequent Entry Biologic Product Table 83. Celltrion Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 84. Celltrion Recent Development Table 85. Biocon Company Details Table 86. Biocon Business Overview Table 87. Biocon Bio Similars/Subsequent Entry Biologic Product Table 88. Biocon Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 89. Biocon Recent Development Table 90. Amgen Company Details Table 91. Amgen Business Overview Table 92. Amgen Bio Similars/Subsequent Entry Biologic Product Table 93. Amgen Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 94. Amgen Recent Development Table 95. Samsung Biologics Company Details Table 96. Samsung Biologics Business Overview Table 97. Samsung Biologics Bio Similars/Subsequent Entry Biologic Product Table 98. Samsung Biologics Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 99. Samsung Biologics Recent Development Table 100. Mylan Company Details Table 101. Mylan Business Overview Table 102. Mylan Bio Similars/Subsequent Entry Biologic Product Table 103. Mylan Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 104. Mylan Recent Development Table 105. Dr. Reddy's Laboratories Company Details Table 106. Dr. Reddy's Laboratories Business Overview Table 107. Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Product Table 108. Dr. Reddy's Laboratories Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 109. Dr. Reddy's Laboratories Recent Development Table 110. Stada Arzneimittel AG Company Details Table 111. Stada Arzneimittel AG Business Overview Table 112. Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Product Table 113. Stada Arzneimittel AG Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 114. Stada Arzneimittel AG Recent Development Table 115. AbbVie Company Details Table 116. AbbVie Business Overview Table 117. AbbVie Bio Similars/Subsequent Entry Biologic Product Table 118. AbbVie Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 119. AbbVie Recent Development Table 120. Sanofi-Aventis Company Details Table 121. Sanofi-Aventis Business Overview Table 122. Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Product Table 123. Sanofi-Aventis Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 124. Sanofi-Aventis Recent Development Table 125. Johnson & Johnson Company Details Table 126. Johnson & Johnson Business Overview Table 127. Johnson & Johnson Bio Similars/Subsequent Entry Biologic Product Table 128. Johnson & Johnson Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 129. Johnson & Johnson Recent Development Table 130. Novo Nordisk Company Details Table 131. Novo Nordisk Business Overview Table 132. Novo Nordisk Bio Similars/Subsequent Entry Biologic Product Table 133. Novo Nordisk Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 134. Novo Nordisk Recent Development Table 135. Eli Lilly Company Details Table 136. Eli Lilly Business Overview Table 137. Eli Lilly Bio Similars/Subsequent Entry Biologic Product Table 138. Eli Lilly Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 139. Eli Lilly Recent Development Table 140. Novartis Company Details Table 141. Novartis Business Overview Table 142. Novartis Bio Similars/Subsequent Entry Biologic Product Table 143. Novartis Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 144. Novartis Recent Development Table 145. 3sbio Company Details Table 146. 3sbio Business Overview Table 147. 3sbio Bio Similars/Subsequent Entry Biologic Product Table 148. 3sbio Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 149. 3sbio Recent Development Table 150. Biotech Company Details Table 151. Biotech Business Overview Table 152. Biotech Bio Similars/Subsequent Entry Biologic Product Table 153. Biotech Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 154. Biotech Recent Development Table 155. Gelgen Company Details Table 156. Gelgen Business Overview Table 157. Gelgen Bio Similars/Subsequent Entry Biologic Product Table 158. Gelgen Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 159. Gelgen Recent Development Table 160. Innovent Company Details Table 161. Innovent Business Overview Table 162. Innovent Bio Similars/Subsequent Entry Biologic Product Table 163. Innovent Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 164. Innovent Recent Development Table 165. Dong Bao Company Details Table 166. Dong Bao Business Overview Table 167. Dong Bao Bio Similars/Subsequent Entry Biologic Product Table 168. Dong Bao Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 169. Dong Bao Recent Development Table 170. Ganlee Company Details Table 171. Ganlee Business Overview Table 172. Ganlee Bio Similars/Subsequent Entry Biologic Product Table 173. Ganlee Revenue in Bio Similars/Subsequent Entry Biologic Business (2017-2022) & (US$ Million) Table 174. Ganlee Recent Development Table 175. Research Programs/Design for This Report Table 176. Key Data Information from Secondary Sources Table 177. Key Data Information from Primary Sources List of Figures Figure 1. Bio Similars/Subsequent Entry Biologic Product Picture Figure 2. Global Bio Similars/Subsequent Entry Biologic Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Bio Similars/Subsequent Entry Biologic Market Size 2017-2028 (US$ Million) Figure 4. United States Bio Similars/Subsequent Entry Biologic Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Bio Similars/Subsequent Entry Biologic Market Size 2017-2028 (US$ Million) Figure 6. United States Bio Similars/Subsequent Entry Biologic Market Share in Global 2017-2028 Figure 7. Bio Similars/Subsequent Entry Biologic Report Years Considered Figure 8. Product Picture of Monoclonal Antibodies Figure 9. Product Picture of Interferon Figure 10. Product Picture of Erythropoietin Figure 11. Product Picture of Insulin Figure 12. Product Picture of Vaccines Figure 13. Product Picture of Other Figure 14. Global Bio Similars/Subsequent Entry Biologic Market Share by Type in 2022 & 2028 Figure 15. Global Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2028) & (US$ Million) Figure 16. Global Bio Similars/Subsequent Entry Biologic Market Share by Type (2017-2028) Figure 17. United States Bio Similars/Subsequent Entry Biologic Market Share by Type in 2022 & 2028 Figure 18. United States Bio Similars/Subsequent Entry Biologic Market Size by Type (2017-2028) & (US$ Million) Figure 19. United States Bio Similars/Subsequent Entry Biologic Market Share by Type (2017-2028) Figure 20. Product Picture of Tumor Figure 21. Product Picture of Diabetes Figure 22. Product Picture of Cardiovascular Figure 23. Product Picture of Hemophilia Figure 24. Product Picture of Other Figure 25. Global Bio Similars/Subsequent Entry Biologic Market Share by Application in 2022 & 2028 Figure 26. Global Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2028) & (US$ Million) Figure 27. Global Bio Similars/Subsequent Entry Biologic Market Share by Application (2017-2028) Figure 28. United States Bio Similars/Subsequent Entry Biologic Market Share by Application in 2022 & 2028 Figure 29. United States Bio Similars/Subsequent Entry Biologic Market Size by Application (2017-2028) & (US$ Million) Figure 30. United States Bio Similars/Subsequent Entry Biologic Market Share by Application (2017-2028) Figure 31. North America Bio Similars/Subsequent Entry Biologic Market Size Growth Rate 2017-2028 (US$ Million) Figure 32. U.S. Bio Similars/Subsequent Entry Biologic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Canada Bio Similars/Subsequent Entry Biologic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Europe Bio Similars/Subsequent Entry Biologic Market Size Growth Rate 2017-2028 (US$ Million) Figure 35. Germany Bio Similars/Subsequent Entry Biologic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. France Bio Similars/Subsequent Entry Biologic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. U.K. Bio Similars/Subsequent Entry Biologic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. Italy Bio Similars/Subsequent Entry Biologic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Russia Bio Similars/Subsequent Entry Biologic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size Growth Rate 2017-2028 (US$ Million) Figure 41. China Bio Similars/Subsequent Entry Biologic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Japan Bio Similars/Subsequent Entry Biologic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. South Korea Bio Similars/Subsequent Entry Biologic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. India Bio Similars/Subsequent Entry Biologic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Australia Bio Similars/Subsequent Entry Biologic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Taiwan Bio Similars/Subsequent Entry Biologic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Indonesia Bio Similars/Subsequent Entry Biologic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Thailand Bio Similars/Subsequent Entry Biologic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Malaysia Bio Similars/Subsequent Entry Biologic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Philippines Bio Similars/Subsequent Entry Biologic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Latin America Bio Similars/Subsequent Entry Biologic Market Size Growth Rate 2017-2028 (US$ Million) Figure 52. Mexico Bio Similars/Subsequent Entry Biologic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. Brazil Bio Similars/Subsequent Entry Biologic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. Argentina Bio Similars/Subsequent Entry Biologic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 55. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size Growth Rate 2017-2028 (US$ Million) Figure 56. Turkey Bio Similars/Subsequent Entry Biologic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 57. Saudi Arabia Bio Similars/Subsequent Entry Biologic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 58. U.A.E Bio Similars/Subsequent Entry Biologic Market Size Growth Rate (2017-2028) & (US$ Million) Figure 59. Sun Pharma Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 60. Synthon Pharmaceuticals Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 61. Teva Pharmaceutical Industries Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 62. LG Life Sciences Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 63. Celltrion Biocon Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 64. Hospira Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 65. Merck Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 66. Biogen idec Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 67. Genentech (Roche) Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 68. Pfizer Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 69. Celltrion Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 70. Biocon Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 71. Amgen Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 72. Samsung Biologics Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 73. Mylan Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 74. Dr. Reddy's Laboratories Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 75. Stada Arzneimittel AG Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 76. AbbVie Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 77. Sanofi-Aventis Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 78. Johnson & Johnson Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 79. Novo Nordisk Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 80. Eli Lilly Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 81. Novartis Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 82. 3sbio Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 83. Biotech Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 84. Gelgen Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 85. Innovent Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 86. Dong Bao Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 87. Ganlee Revenue Growth Rate in Bio Similars/Subsequent Entry Biologic Business (2017-2022) Figure 88. Bottom-up and Top-down Approaches for This Report Figure 89. Data Triangulation Figure 90. Key Executives Interviewed
Sun Pharma Synthon Pharmaceuticals Teva Pharmaceutical Industries LG Life Sciences Celltrion Biocon Hospira Merck Biogen idec Genentech (Roche) Pfizer Celltrion Biocon Amgen Samsung Biologics Mylan Dr. Reddy's Laboratories Stada Arzneimittel AG AbbVie Sanofi-Aventis Johnson & Johnson Novo Nordisk Eli Lilly Novartis 3sbio Biotech Gelgen Innovent Dong Bao Ganlee
Juice, Nectar and Still Drinks market is segmented by region (country), players, by Type and by A ... Read More
Coke for Electrode market is segmented by region (country), players, by Type and by Application. ... Read More
Butene Propylene Copolymer market is segmented by region (country), players, by Type and by Appli ... Read More
Formoterol market is segmented by region (country), players, by Type and by Application. Players, ... Read More